Alf Kristian Berg

Alf Kristian Berg is a researcher affiliated with the University of Oslo's Section for Galenic Pharmacy and Community Pharmacy. His work focuses on advancing drug delivery systems through photochemical internalization (PCI), photodynamic therapy (PDT), and nanomedicine. Key research areas include enhancing cancer treatment efficacy via light-activated drug delivery mechanisms, targeting cancer stem cells, and developing novel therapeutic biomaterials.

His research has been published in high-impact journals such as Nature Communications, Cancers, and Frontiers in Immunology. Major contributions include demonstrating PCI's role in bypassing biological barriers (e.g., blood-brain barrier) and improving chemotherapy/gene therapy outcomes. Collaborations span institutions like the University of Manchester and the University of Leeds, emphasizing translational applications of his findings.

Despite no explicitly listed awards, his extensive publication record reflects significant contributions to photomedicine and oncology. His lab's work integrates molecular biology, biophysics, and engineering to address unmet clinical needs in targeted therapies.